Document is current
Any future updates will be listed below
-
Authors
Neville, Matthew D. C. https://orcid.org/0000-0001-5816-7936
Lawson, Andrew R. J. https://orcid.org/0000-0003-3592-1005
Sanghvi, Rashesh https://orcid.org/0000-0002-7703-9216
Abascal, Federico https://orcid.org/0000-0002-6201-1587
Pham, My H. https://orcid.org/0000-0002-0074-0733
Cagan, Alex https://orcid.org/0000-0002-7857-4771
Nicola, Pantelis A.
Bayzetinova, Tetyana
Baez-Ortega, Adrian
Roberts, Kirsty
Lensing, Stefanie V.
Widaa, Sara
Alcantara, Raul E.
García, María Paz
Wadge, Sam
Stratton, Michael R. https://orcid.org/0000-0001-6035-153X
Campbell, Peter J. https://orcid.org/0000-0002-3921-0510
Small, Kerrin https://orcid.org/0000-0003-4566-0005
Martincorena, Iñigo https://orcid.org/0000-0003-1122-4416
Hurles, Matthew E. https://orcid.org/0000-0002-2333-7015
Rahbari, Raheleh https://orcid.org/0000-0002-1839-7785
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 23 July 2025
First Online: 8 October 2025
Competing interests
: I.M., M.R.S. and P.J.C. are co-founders, shareholders and consultants for Quotient Therapeutics. R.E.A. is an employee of Quotient Therapeutics. M.E.H. is a co-founder of, consultant to and holds shares in Congenica, a genetics diagnostic company. The remaining authors declare no competing interests.
